Senores Pharmaceuticals Ltd
NSE: SENORES BSE: 544319
₹723.90
(-3.69%)
Thu, 02 Apr 2026, 00:29 am
Market Cap34.61B
PE Ratio32.81
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2017
- The company was originally incorporated as Senores Pharmaceuticals Private Limited.
2021
- Incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc, in the US.
- Entered into a new segment of API with the acquisition of Ratnagene Lifescience Private Limited.
2022
- Started the domestic business with the launch of critical care injectables.
2023
- Changed the company name to Senores Pharmaceuticals Limited upon conversion to a public limited company.
- Received approval from the central government for the name change.
- Obtained a fresh certificate of incorporation reflecting the name change.
2024
- Launched first CMO product in the US with Jubilant Cadista.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800